105 related articles for article (PubMed ID: 21209384)
1. Cholesterol regulates VEGFR-1 (FLT-1) expression and signaling in acute leukemia cells.
Casalou C; Costa A; Carvalho T; Gomes AL; Zhu Z; Wu Y; Dias S
Mol Cancer Res; 2011 Feb; 9(2):215-24. PubMed ID: 21209384
[TBL] [Abstract][Full Text] [Related]
2. Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-gamma and migration of endothelial cells expressing Flt 1.
Landgren E; Schiller P; Cao Y; Claesson-Welsh L
Oncogene; 1998 Jan; 16(3):359-67. PubMed ID: 9467961
[TBL] [Abstract][Full Text] [Related]
3. VEGFR-1 (FLT-1) activation modulates acute lymphoblastic leukemia localization and survival within the bone marrow, determining the onset of extramedullary disease.
Fragoso R; Pereira T; Wu Y; Zhu Z; Cabeçadas J; Dias S
Blood; 2006 Feb; 107(4):1608-16. PubMed ID: 16249383
[TBL] [Abstract][Full Text] [Related]
4. Flt-1 signaling in macrophages promotes glioma growth in vivo.
Kerber M; Reiss Y; Wickersheim A; Jugold M; Kiessling F; Heil M; Tchaikovski V; Waltenberger J; Shibuya M; Plate KH; Machein MR
Cancer Res; 2008 Sep; 68(18):7342-51. PubMed ID: 18794121
[TBL] [Abstract][Full Text] [Related]
5. Expression of vascular endothelial growth factor, placental growth factor, and their receptors Flt-1 and KDR in human placenta under pathologic conditions.
Kumazaki K; Nakayama M; Suehara N; Wada Y
Hum Pathol; 2002 Nov; 33(11):1069-77. PubMed ID: 12454810
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor receptor-1 and receptor-2 initiate a phosphatidylinositide 3-kinase-dependent clonogenic response in acute myeloid leukemia cells.
List AF; Glinsmann-Gibson B; Stadheim C; Meuillet EJ; Bellamy W; Powis G
Exp Hematol; 2004 Jun; 32(6):526-35. PubMed ID: 15183893
[TBL] [Abstract][Full Text] [Related]
7. Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration.
Dias S; Hattori K; Zhu Z; Heissig B; Choy M; Lane W; Wu Y; Chadburn A; Hyjek E; Gill M; Hicklin DJ; Witte L; Moore MA; Rafii S
J Clin Invest; 2000 Aug; 106(4):511-21. PubMed ID: 10953026
[TBL] [Abstract][Full Text] [Related]
8. Induction of vascular endothelial growth factor secretion by childhood acute lymphoblastic leukemia cells via the FLT-3 signaling pathway.
Markovic A; MacKenzie KL; Lock RB
Mol Cancer Ther; 2012 Jan; 11(1):183-93. PubMed ID: 22084166
[TBL] [Abstract][Full Text] [Related]
9. Coculture in vitro with endothelial cells induces cytarabine resistance of acute myeloid leukemia cells in a VEGF-A/VEGFR-2 signaling-independent manner.
Okamoto S; Miyano K; Kitakaze K; Kato H; Yamauchi A; Kajikawa M; Itsumi M; Kawai C; Kuribayashi F
Biochem Biophys Res Commun; 2022 Jan; 587():78-84. PubMed ID: 34872003
[TBL] [Abstract][Full Text] [Related]
10. VEGFR-1 (FLT-1), beta1 integrin, and hERG K+ channel for a macromolecular signaling complex in acute myeloid leukemia: role in cell migration and clinical outcome.
Pillozzi S; Brizzi MF; Bernabei PA; Bartolozzi B; Caporale R; Basile V; Boddi V; Pegoraro L; Becchetti A; Arcangeli A
Blood; 2007 Aug; 110(4):1238-50. PubMed ID: 17420287
[TBL] [Abstract][Full Text] [Related]
11. [Dynamic observation of vascular endothelial growth factor (VEGF)/VEGF-receptors expression in acute leukemia].
Wang C; Chen FY; Zhu JS; Xu YP; Han JY; Ouyang RR
Zhonghua Nei Ke Za Zhi; 2004 Nov; 43(11):845-8. PubMed ID: 15634546
[TBL] [Abstract][Full Text] [Related]
12. Early signaling by vascular endothelial growth factor and placental growth factor in human bone marrow-derived endothelial cells is mediated by superoxide.
Dhar-Mascareno M; Mascareno E; Golde DW
J Vasc Res; 2009; 46(6):601-8. PubMed ID: 19571580
[TBL] [Abstract][Full Text] [Related]
13. Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor.
Sawano A; Takahashi T; Yamaguchi S; Aonuma M; Shibuya M
Cell Growth Differ; 1996 Feb; 7(2):213-21. PubMed ID: 8822205
[TBL] [Abstract][Full Text] [Related]
14. VEGF signaling on hematopoietic precursors restricts B-lymphoid commitment in vitro and in vivo.
Fragoso R; Igreja C; Clode N; Henriques A; Appleton C; Zhu Z; Wu Y; Dias S
Exp Hematol; 2008 Oct; 36(10):1329-1336. PubMed ID: 18620797
[TBL] [Abstract][Full Text] [Related]
15. The basis for the distinct biological activities of vascular endothelial growth factor receptor-1 ligands.
Anisimov A; Leppänen VM; Tvorogov D; Zarkada G; Jeltsch M; Holopainen T; Kaijalainen S; Alitalo K
Sci Signal; 2013 Jul; 6(282):ra52. PubMed ID: 23821770
[TBL] [Abstract][Full Text] [Related]
16. VEGFR-1-selective VEGF homologue PlGF is arteriogenic: evidence for a monocyte-mediated mechanism.
Pipp F; Heil M; Issbrücker K; Ziegelhoeffer T; Martin S; van den Heuvel J; Weich H; Fernandez B; Golomb G; Carmeliet P; Schaper W; Clauss M
Circ Res; 2003 Mar; 92(4):378-85. PubMed ID: 12600898
[TBL] [Abstract][Full Text] [Related]
17. Disease-specific expression of VEGF and its receptors in AML cells: possible autocrine pathway of VEGF/type1 receptor of VEGF in t(15;17) AML and VEGF/type2 receptor of VEGF in t(8;21) AML.
Hiramatsu A; Miwa H; Shikami M; Ikai T; Tajima E; Yamamoto H; Imai N; Hattori A; Kyo T; Watarai M; Miura K; Satoh A; Itoh M; Imamura A; Mihara H; Katoh Y; Nitta M
Leuk Lymphoma; 2006 Jan; 47(1):89-95. PubMed ID: 16465716
[TBL] [Abstract][Full Text] [Related]
18. Roles of VEGF-Flt-1 signaling in malignant behaviors of oral squamous cell carcinoma.
Subarnbhesaj A; Miyauchi M; Chanbora C; Mikuriya A; Nguyen PT; Furusho H; Ayuningtyas NF; Fujita M; Toratani S; Takechi M; Niida S; Takata T
PLoS One; 2017; 12(11):e0187092. PubMed ID: 29149180
[TBL] [Abstract][Full Text] [Related]
19. Colocalization of the VEGF-R2 and the common IL-3/GM-CSF receptor beta chain to lipid rafts leads to enhanced p38 activation.
Saulle E; Riccioni R; Coppola S; Parolini I; Diverio D; Riti V; Mariani G; Laufer S; Sargiacomo M; Testa U
Br J Haematol; 2009 May; 145(3):399-411. PubMed ID: 19245429
[TBL] [Abstract][Full Text] [Related]
20. Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.
Lu D; Jimenez X; Zhang H; Wu Y; Bohlen P; Witte L; Zhu Z
Cancer Res; 2001 Oct; 61(19):7002-8. PubMed ID: 11585724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]